Autres langues Amphastar Pharmaceuticals, Inc.

Actions

AMPH

US03209R1032

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 26/08/2026			Varia. 5j.	Varia. 1 janv.
22,02 ^USD	+0,18%		+1,29%	-17,77%

18/08	Amphastar Pharmaceuticals, Inc. : Barclays toujours neutre sur le dossier	ZM
07/08	Transcript : Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026

Autres langues

07/08	Amphastar Pharmaceuticals : Reports Financial Results for the Three Months Ended June 30, 2026
06/08	Amphastar: Q2 Earnings Snapshot
06/08	Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016.
06/08	Earnings Flash (AMPH) Amphastar Pharmaceuticals, Inc. Posts Q2 Adjusted EPS $0.91 per Share, vs. FactSet Est of $0.62
06/08	Earnings Flash (AMPH) Amphastar Pharmaceuticals, Inc. Reports Q2 Revenue $183.9M, vs. FactSet Est of $179.9M
06/08	Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
30/07	Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026
13/07	Amphastar Pharmaceuticals, Inc. Announces Board Changes, Effective July 9, 2026
08/07	Amphastar Unit Receives US FDA Warning Letter on Violations at California Facility
08/07	Amphastar Receives Warning Letter from FDA for Facility's Manufacturing Practices
29/06	Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell Small Cap Comp Growth Benchmark
29/06	Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2500 Growth Benchmark
29/06	Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2000 Growth Benchmark
29/06	Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 3000E Growth Benchmark
29/06	Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2000 Growth-Defensive Index
29/06	Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) added to Russell 2000 Dynamic Index
29/06	Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 3000 Growth Benchmark
17/06	Amphastar Pharmaceuticals Inc Receives FDA Approval for Over-The-Counter Rextovy Naloxone Nasal Spray
16/06	Health Care Flat as Traders Rotate Into Laggards From Tech - Health Care Roundup
16/06	Amphastar Pharmaceuticals Gets FDA Approval for Over-The-Counter Nasal Spray for Opioid Overdose
27/05	Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
14/05	Amphastar Shares Fall After Wells Fargo Downgrade
12/05	Amphastar Pharmaceuticals : 2026 Bank of America Health Care Conference
08/05	Amphastar Pharmaceuticals : Q1 Financial Results (news)
08/05	Amphastar Pharmaceuticals : Quarterly Report for Quarter Ending 2026-03-31 (Form 10-Q)